Our News on Newswise

Moffitt Researchers Develop HER3-Specific Dendritic Cell Cancer Vaccine

Researchers at Moffitt Cancer Center are working to develop a dendritic cell vaccine targeting HER3, a protein involved in the growth and spread of many different cancer types. Their pre-clinical work has been published in the journal Cancer...
1-Dec-2021 9:00 AM EST Add to Favorites

Moffitt Researchers Use Computer Modeling to Predict Patient Tumor Responses to Radiation Therapy

Researchers at Moffitt Cancer Center are trying to improve the personalization of radiation therapy through computer modeling. In a new study published in the journal Neoplasia, they model how interactions between cancer cells and immune cells, and...
18-Oct-2021 11:35 AM EDT Add to Favorites

Newswise: 615c53ad51002_IMG_0095-Ana Da Silva Gomes.jpg

Moffitt Researcher Receives NIH Director’s New Innovator Award

Ana Gomes, Ph.D., assistant member of Moffitt’s Molecular Oncology Department, has been awarded a National Institutes of Health (NIH) Director’s New Innovator (DP2) Award. The five-year grant will fund research aimed at understanding how...
5-Oct-2021 11:15 AM EDT Add to Favorites

Moffitt Cancer Center’s National Cancer Institute Designation Renewed

Moffitt Cancer Center has once again been awarded the National Cancer Institute’s highest designation, Comprehensive Cancer Center, with its highest ranking ever.
20-Sep-2021 10:00 AM EDT Add to Favorites

Moffitt Participating in National Pilot Project to Increase Diversity in Clinical Trials

Moffitt Cancer Center is participating in a national pilot project being conducted by the American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC). The pilot project is testing a research site...
16-Sep-2021 10:00 AM EDT Add to Favorites

Patients Treated with Immune Checkpoint Inhibitors Have Better Quality of Life, Moffitt Analysis Shows

In a new article published in the Journal of the National Cancer Institute, Moffitt Cancer Center researchers report that patients treated with immune checkpoint inhibitors have a higher self-reported quality of life than patients treated with other...
14-Sep-2021 9:00 AM EDT Add to Favorites

Moffitt Cancer Center Joins Dana-Farber Cancer Institute to Help Stop Blood Cancer

Moffitt Cancer Center has joined Dana-Farber Cancer Institute to provide free screenings to eligible adults who are at a higher risk for having or developing multiple myeloma or other related conditions. This initiative is through the PROMISE Study,...
8-Sep-2021 10:00 AM EDT Add to Favorites

Moffitt Researchers Develop Model to Predict Non-Small Cell Lung Cancer Patient Outcomes to Immunotherapy

In a new article published in JNCI Cancer Spectrum, Moffitt Cancer Center researchers describe a prediction model they have created that includes information calculated from computed tomography images that can identify non-small cell lung cancer...
20-Aug-2021 9:00 AM EDT Add to Favorites


See All News

Our Experts on Newswise

CANCER AND COVID-19: Moffitt Cancer Center Experts & Resources

1-Apr-2020 8:40 AM EDT

Newswise: AnnaGiuliano_Euroginopeningtalk_2017.jpg

Moffitt Cancer Center HPV Expert Kicked Off EUROGIN Conference

Anna Giuliano, Ph.D., director of Moffitt Cancer Center’s Center for Infection Research in Cancer, delivered the opening keynote address at the 2017 European Research Organization on Genital Infection and Neoplasia (EUROGIN) International...
10-Oct-2017 10:05 AM EDT

See All Experts

Our YouTube Videos

About

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is the No. 11 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 7,000 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter, Instagram and YouTube.

Contacts

Kim Polacek
Senior Public Relations Account Coordinator

Kim.Polacek@Moffitt.org

813-745-7408

Steven Blanchard
Public Relations Account Coordinator

Steven.Blanchard@Moffitt.org

813-745-1718

Patty Kim
Public Relations Manager

Patty.Kim@Moffitt.org

813-745-7322

Pat Carragher
Public Relations Account Coordinator

Pat.Carragher@Moffitt.org

Twitter

close
0.31714